Table 31cKoliopoulos et al36: Sensitivity Analysis Showing Expected Colposcopies, Incremental Colposcopies, Life-Years, Incremental Life-Years, and Incremental Colposcopies per Life-Year for Strategies Identified as Efficient*

StrategyColposcopiesIncremental ColposcopiesLife Years (LYs)Incremental LYsICLY
No intervention069016.30
Cytology, q5, Age 2169469469205.11188.814
Cytology and HPV, q5, Age 3090721369226.6621.5510
Cytology and HPV, q3, Age 30121030369240.1413.4822
Cytology and HPV, q2, Age 30164643669245.205.0686
Cytology and HPV, q1, Age 30214249669249.404.20118
Cytology, q1, Age 21274460269251.101.70354
*

Per 1,000 women. Women are assumed to begin screening at age 21 years. Screening intervals of every 1 (q1), 2 (q2), 3 (q3), and 5 (q5) years are compared.

From: Results

Cover of Screening for Cervical Cancer: A Decision Analysis for the U.S. Preventive Services Task Force
Screening for Cervical Cancer: A Decision Analysis for the U.S. Preventive Services Task Force [Internet].
Evidence Syntheses, No. 86s.
Kulasingam SL, Havrilesky L, Ghebre R, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.